National HIV Curriculum
The BEe-HIVe Study: Major Findings from Two Publications
24:31
National HIV Curriculum
Histoplasmosis: Prophylaxis and Treatment in People with HIV
15:21
National HIV Curriculum
Hepatitis C and HIV Coinfection: Diagnosis and Management
25:11
National HIV Curriculum
PML: Evaluation and Management
17:31
National HIV Curriculum
Integrating Injectable ART into Clinical Practice
41:37
National HIV Curriculum
Initial Laboratory Evaluation of a Person with HIV
17:45
National HIV Curriculum
CROI 2025: Four More Potentially Practice-Changing Abstracts
24:15
National HIV Curriculum
CROI 2025: CARES and BEeHIVe Studies and Their Potential Practice-Changing Impacts
23:33
National HIV Curriculum
Initial Visit & Evaluation for a Person with HIV
17:06
National HIV Curriculum
LATITUDE Study: Interim Findings and Implications
47:45
National HIV Curriculum
Mini-Lecture Series: Bictegravir-Tenofovir alafenamide-Emtricitabine
17:19
National HIV Curriculum
Neurosyphilis: Evaluation and Management
22:32
National HIV Curriculum
Switching ART Regimens: A Discussion
36:01
National HIV Curriculum
Mini-Lecture Series: Guideline Update: HHS Adult & Adolescent Antiretroviral Treatment Guidelines
19:25
National HIV Curriculum
Disseminated MAC: Evaluation and Management
23:21
National HIV Curriculum
Mini-Lecture Series: Progressive Multifocal Leukoencephalopathy (PML)
8:43
National HIV Curriculum
Initial ART Regimens Considerations: A Discussion
23:44
National HIV Curriculum
Implementation of the New HHS Anal Cancer Screening Guidelines
40:45
National HIV Curriculum
Mini-Lecture Series: Parasitic Diarrheal Opportunistic Infections in People with HIV
9:42
National HIV Curriculum
Pneumocystis Pneumonia: Management
17:17
National HIV Curriculum
The ANCHOR Study: Does Treatment of Anal HSIL Prevent Anal Cancer?
16:16
National HIV Curriculum
NHC Learning Group Video
7:04
National HIV Curriculum
Mini-Lecture Series: Disseminated Mycobacterium Avium Complex (MAC): Prophylaxis and Treatment
13:30
National HIV Curriculum
Evaluation of Dyspnea in a Person with Advanced HIV
26:40
National HIV Curriculum
Mini-Lecture Series: Cytomegalovirus (CMV) Retinitis: Treatment
13:31
National HIV Curriculum
Semaglutide Studies in PWH & What to Consider Before Prescribing
31:03
National HIV Curriculum
Mini-Lecture Series: HIV Capsid Inhibitors: Mechanism of Action
17:21
National HIV Curriculum
The SLIM LIVER Study: Use of Semaglutide for Persons with HIV
24:02
National HIV Curriculum
CMV Retinitis: Evaluation and Management
24:15
National HIV Curriculum
Mini-Lecture Series: Dolutegravir-Rilpivirine
7:55
National HIV Curriculum
Mini-Lecture Series: HIV Entry Inhibitors: Mechanism of Action
18:08
National HIV Curriculum
Should People with HIV Take Aspirin for CVD Prevention?
14:50
National HIV Curriculum
Toxoplasma Encephalitis: Management
17:49
National HIV Curriculum
Mini-Lecture Series: Pneumocystis Pneumonia: Prevention
8:31
National HIV Curriculum
Mini-Lecture Series: Guideline Update: Statins for Primary Prevention of CVD for PWH
14:33
National HIV Curriculum
Mini-Lecture Series: Pneumocystis Pneumonia: Treatment
12:37
National HIV Curriculum
Cardiovascular Side Effects of Antiretroviral Therapy
20:04
National HIV Curriculum
Evaluation of Focal Neurological Symptoms in a Patient with Advanced HIV
13:18
National HIV Curriculum
Mini-Lecture Series: Toxoplasma Encephalitis: Prevention
10:18
National HIV Curriculum
Mini-Lecture Series: Treatment of Toxoplasma Encephalitis
12:58
National HIV Curriculum
New Guidelines: Statin Therapy for People with HIV to Prevent CVD
22:55
National HIV Curriculum
Pharmacologic Management of Hyperlipidemia
23:44
National HIV Curriculum
Management of Cryptococcal Meningitis
22:16
National HIV Curriculum
REPRIEVE Statin Trial: Why is It Important?
22:22
National HIV Curriculum
Evaluation of a Headache in Advanced HIV
22:00
National HIV Curriculum
Antiretroviral Therapy (ART) and Weight Gain
32:53
National HIV Curriculum
Mini Lecture Series: Management of HCV and HIV Coinfection
15:07
National HIV Curriculum
Mini Lecture Series: Long-Acting, Injectable Cabotegravir-Rilpivirine (CAB-RPV)
20:47
National HIV Curriculum
Mini-Lecture Series: Dolutegravir-Abacavir-Lamivudine
15:09
National HIV Curriculum
Mini-Lecture Series: Review of 2021 Updates to the Cryptococcal Disease Treatment Guidelines
11:17
National HIV Curriculum
Mini-Lecture Series: Boosted Darunavir
14:46
National HIV Curriculum
Mini-Lecture Series: 2022 ID Week Conference Summary
11:17
National HIV Curriculum
Mini-Lecture Series: Recent Updates on Three Immunization Recommendations for Persons with HIV
15:37
National HIV Curriculum
Mini-Lectures: Introduction to the Biology of HIV-1
25:16
National HIV Curriculum
Mini-Lecture Series: Overview of the HIV Life Cycle
30:17
National HIV Curriculum
Mini-Lecture Series: New LTBI Treatment Guidelines
11:07
National HIV Curriculum
Mini-Lecture Series: Dolutegravir-Lamivudine
8:20
National HIV Curriculum
Mini-Lecture Series: Darunavir-Cobicistat-Tenofovir-Emtricitabine
16:35
National HIV Curriculum
Mini-Lecture Series: Ibalizumab
14:41
National HIV Curriculum
Mini-Lecture Series: Doravirine
7:24
National HIV Curriculum
Mini-Lecture Series: Maraviroc
11:44
National HIV Curriculum
Mini-Lecture Series: Fostemsavir
12:54